VJHemOnc is committed to improving our service to you

MDS 2020 | MicroRNA signatures in MDS

VJHemOnc is committed to improving our service to you

Inga Mandac

Inga Mandac, MD, Clinical Hospital Merkur, Zagreb, Croatia, discusses the role of microRNA’s in the pathogenesis of MDS and how impoving our understanding of microRNA will allow for the stratification of patients and provide new potential treatment options for MDS. This interview took place at the 2nd Regional Symposium on Myelodysplastic Syndromes (MDS 2020), held in Tel Aviv, Israel.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter